After noticing a rate of severe allergic reactions higher than expected (1 in 20,000 vaccinations rather than the expected 1 in 100,000 vaccinations) GSK has asked provincial governments using vaccine from one particular lot shipment to stop using it. I am pleased to see the company taking this seriously and monitoring for statistically anomalies post-vaccination. Details here. See also here.